image
SAB Biotherapeutics, Inc. SABS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.72
-1.71 %
$ 16 M
Market Cap
-0.46
P/E
Price Target Average
229.46%
Revenue Forecast Estimate
144.24%
EBIT Estimate
12.49%
Net Income Estimate
19.07%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets SAB Biotherapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for SABS of $5.67 , with forecasts ranging from a low of $3 to a high of $8 .
SABS Lowest Price Target Wall Street Target
3 USD 74.42%
SABS Average Price Target Wall Street Target
5.67 USD 229.46%
SABS Highest Price Target Wall Street Target
8 USD 365.12%
Price
Max Price Target
Min Price Target
Average Price Target
8877665544332211Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart SABS

image
$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart SABS

image
$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart SABS

image
$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)202120212022202220232023202420242025202520262026202720272028202820292029